Over the last 2 decades, significant progress has been made in our understanding of the genomics, tumor immune microenvironment, and immunogenicity of malignant melanoma. Historically, the prognosis ...
Bristol Myers Squibb has linked its CD19-directed CAR-T cell therapy to sustained clinical responses in people with systemic ...
Four Purdue professors were recently appointed Showalter Faculty Scholars. The addition of Leifu Chang, Bruno Roseguini, Jonathan Shannahan and Mohit Verma brings the number ...
Clinical data from the RESET-Myositis™ and RESET-SLE™ trials, along with initial clinical data from the RESET-SSc™ trial, to be presented this ...
T cells serve an important role in coordinating immune responses and removing pathogen-infected ... India's first home-grown ...
Credit: Sara Mangsbo/Johan Rockberg The drug redirects the immune system to find and target specific mutations and gene ...
Professor Nancy Ip discusses her groundbreaking neuroscience research, focusing on neurotrophic factors and innovative ...
Ireland has a golden opportunity to build on existing scientific, biomanufacturing, and clinical strengths and create a unique ecosystem to rival other, more established centres in Europe. The ...
CAR-T therapy leverages the body’s immune system to target and eliminate cancer cells ... which enhances their ability to ...
Fred Hutch Cancer Center researchers developing immunotherapies using engineered adaptive immune system ... including the TCR ...
Intrinsic Tumor Drivers and Immune Escape Mechanisms in CD19 CAR T-Cell Therapy Resistance for Aggressive Large B ...